Literature DB >> 19164362

ST-segment depression as a risk factor in hypertrophic cardiomyopathy.

Majid Haghjoo1, Shabnam Mohammadzadeh, Mehdi Taherpour, Babak Faghfurian, Amir Farjam Fazelifar, Abolfath Alizadeh, Mohammad Asadian Rad, Mohammad Ali Sadr-Ameli.   

Abstract

AIMS: From the spectrum of electrocardiogram (ECG) changes that may occur in hypertrophic cardiomyopathy (HCM), there is no criterion reported to be useful for risk stratification. We sought to determine whether there was a relationship between the resting ECG findings and prognosis in patients with HCM. METHODS AND
RESULTS: We retrospectively analysed data on 173 consecutive patients admitted to our centre with a diagnosis of HCM. The 12-lead ECGs were assessed for underlying rhythm, PR interval, QRS voltages, QRS width, corrected QT interval, ST-segment deviation, T-wave inversion, and left atrial enlargement (LAE). During a mean follow-up of 50 months, 6.4% of patients had a combined endpoint [sudden death or appropriate implantable cardioverter-defibrillator (ICD) therapy]. The frequency of the combined endpoint was greater in patients with syncope, non-sustained ventricular tachycardia, maximal left ventricular (LV) wall thickness >or=30 mm, and ST-segment depression in the high lateral leads (all P < 0.05). Other ECG findings (LV hypertrophy, LAE, abnormal Q wave, abnormal ST-T changes, and underlying rhythm), family history of sudden death, and LV outflow obstruction were not related to the combined endpoint. The results of our multivariate analysis demonstrated that ST-segment depression in the high lateral leads (OR: 20.0, 95% CI: 12.7-27.5; P = 0.0001) and syncope (OR: 19.0, 95% CI: 11.7-26.9; P = 0.0001) were the predictors of sudden death or appropriate ICD therapy in patients with HCM.
CONCLUSION: The results of this study indicated that, in addition to generally accepted risk factors, ST-segment depression in the high lateral leads could be of prognostic significance in HCM patients.

Entities:  

Mesh:

Year:  2009        PMID: 19164362     DOI: 10.1093/europace/eun393

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Association of ST elevation with apical aneurysm in hypertrophic cardiomyopathy.

Authors:  Ozcan Ozeke; Cagatay Ertan; Gokhan Keskin; Bulent Deveci; Serkan Cay; Fırat Ozcan; Serkan Topaloglu; Dursun Aras; Ahmet Duran Demir; Sinan Aydogdu
Journal:  Indian Heart J       Date:  2015-08-08

Review 2.  What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?

Authors:  Ingegerd Östman-Smith
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21

3.  Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.

Authors:  Mahmoud E Youssef; Heba M Abdelrazek; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-10       Impact factor: 3.000

4.  Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score.

Authors:  Ingegerd Östman-Smith; Gunnar Sjöberg; Annika Rydberg; Per Larsson; Eva Fernlund
Journal:  Open Heart       Date:  2017-10-21

5.  Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.

Authors:  Satoshi Higuchi; Yuichiro Minami; Morio Shoda; Shota Shirotani; Chihiro Saito; Shintaro Haruki; Masayuki Gotou; Daigo Yagishita; Koichiro Ejima; Nobuhisa Hagiwara
Journal:  J Am Heart Assoc       Date:  2020-03-09       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.